|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net Income (Loss) | |||||
| Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities: | |||||
| Depreciation, Depletion and Amortization | |||||
| Amortization of Deferred Financing Costs | |||||
| Stock-Based Compensation | |||||
| Gain on Asset Sales and Abandonments, net | |||||
| Loss on Debt Extinguishment | |||||
| (Gain) Loss on Commodity Derivative Instruments | |||||
| Loss on Other Derivative Instruments | |||||
| Net Cash (Paid) Received in Settlement of Commodity Derivative Instruments | |||||
| Deferred Income Taxes | |||||
| Other | |||||
| Changes in Operating Assets: | |||||
| Accounts and Notes Receivable | |||||
| Supplies Inventories | |||||
| Recoverable Income Taxes | |||||
| Prepaid Expenses | |||||
| Changes in Other Assets | |||||
| Changes in Operating Liabilities: | |||||
| Accounts Payable | |||||
| Accrued Interest | |||||
| Other Operating Liabilities | |||||
| Changes in Other Liabilities | |||||
| Net Cash Provided by Operating Activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital Expenditures | |||||
| Proceeds from Asset Sales | |||||
| Investment in Equity Affiliates | |||||
| Apex Acquisition (Net of Cash Acquired) | |||||
| Net Cash Used in Investing Activities | |||||
| Cash Flows from Financing Activities: | |||||
| Payments on Long-Term Notes | |||||
| Net Proceeds from Revolving Credit Facility Borrowings | |||||
| CNXM Revolving Credit Facility | |||||
| CNX Revolving Credit Facility | |||||
| Net Payments on Revolving Credit Facility Borrowings | |||||
| CNXM Revolving Credit Facility | |||||
| CNX Revolving Credit Facility | |||||
| CNXM Senior Notes | |||||
| Proceeds from Issuance of CNX Senior Notes | |||||
| CNX Senior Notes | |||||
| CNXM Senior Notes | |||||
| Payments on Other Debt | |||||
| Proceeds from Issuance of Common Stock | |||||
| Shares Withheld for Taxes | |||||
| Purchases of Common Stock | |||||
| Debt Issuance and Financing Fees | |||||
| Net Cash Used in Financing Activities | |||||
| Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash | |||||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | |||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period | |||||
Loading...